Despite FDA Delays, Experts Anticipate Donanemab Will Be… : Neurology Today
An abstract is unavailable.
An abstract is unavailable.
This study investigates associations of genetically defined vascular traits with all-cause dementia and Alzheimer disease, while accounting for potential epidemiologic biases.
Neuromodulation devices are effective in primary headache management, present low risk, and have minimal to no adverse events but require an understanding of how they…
An abstract is unavailable.
In this study, we looked at factors that related to a person’s decision to seek medical care for migraine in a representative sample of over…
Join us for this and future episodes to learn from experts as they discuss recent Neurology journal articles and hot topics in the field of…
The term “extrapyramidal system/symptoms/signs” and the acronym “EPS” have been abundantly used in neurology and psychiatry literature for more than a century. However, EPS has…
An abstract is unavailable.
Chronic migraine (CM) represents a greater burden to patients with migraine; thus, conversion from CM to episodic migraine (EM) by reducing the frequency of monthly…
Cogniphobia is the fear of cognitive exertion, in which the patient believes effortful thinking triggers or exacerbates headache. The Cogniphobia Scale for Headache Disorders (CS-HD)…
Numerous studies have shown that eptinezumab is effective for migraine prevention, but there have been limited studies in Asian patients. In this six-month real-world study…